OptiBiotix Health Enters Licensing Agreement with Bened Biomedical to Access Asia Pacific Region
OptiBiotix Health plc (AIM: OPTI) announces that it has entered into a three year non-exclusive licence agreement with Bened Biomedical Ltd., Taiwan (“Bened”). The agreement grants Bened a non-exclusive license to produce, package, promote, market, and […]